HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprevalence of IgG antibodies against Echinococcus granulosus in the population of the region of Thessaly, Central Greece.

Abstract
Echinococcosis notification rate in Greece, based on the most recent data, is below 0.25 per 100,000 population. To further investigate the epidemiology of echinococcosis in Greece a study was designed to determine the seroprevalence of Echinococcus granulosus antibodies in the population of Thessaly, Central Greece. Five hundred and forty two left over blood samples in Thessaly laboratories, were collected using a stratified convenient sampling procedure. Samples were analyzed with enzyme linked immunosorbent assay. The seropositivity found was 1.1%(95% C.I., 0.5-2.5), with 5 out of 6 seropositive results to be in the age group of over 65 (OR = 17.95, 95%CI 2.04-157.11, p value 0.009). Rural residence was also found as a risk factor to seropositivity (RR = 7.60, 95% CI 0.89-64.64, p value 0.039). Surveillance data and our study results converge that echinococcosis is being reduced in Greece, with older population to be affected mostly. These might be due to the disease transmission restriction, by the control measures being implemented. Efforts should be continued, in both animals and humans side, by increasing training campaigns and public awareness.
AuthorsVasilios Fotiou, Eleni Malissiova, Anastasios Minas, Efthimia Petinaki, Christos Hadjichristodoulou
JournalPloS one (PLoS One) Vol. 7 Issue 5 Pg. e37112 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22615913 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Helminth
  • Immunoglobulin G
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Animals
  • Antibodies, Helminth (blood)
  • Child
  • Child, Preschool
  • Echinococcosis (blood, epidemiology)
  • Echinococcus granulosus (immunology, isolation & purification)
  • Female
  • Greece (epidemiology)
  • Humans
  • Immunoglobulin G (blood, immunology)
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Risk Factors
  • Rural Population
  • Seroepidemiologic Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: